Member Info for potnak

Swings and roundabouts. If you are happy for the mm's to push the price up when there is liquidity then you have to accept, they will walk it down when there is no liquidity. I still think 50p by Dec. If not multiples of that with a deal inked.

The round numbers help for when you are doing mental arithmetic when out on a run. 500k shares is a good number though. I try not to plan the future with SAR drink in mind. I'm 55 and the plan has always been to retire at 60 either a contingency of 62. If we see market downturns. my sar stock could potentially bring that forward 5 years. I don't particularly like my job but I don't mind working do even £1 a share could see me do something else for a living. £2 is a Cautious retirement, £3 gives me the same lifestyle I have now. £5 is wealthy retiree. 5 to 10 pound and my other half can not work too. She's only 47 so 10 years before she can access pensions.

If you take the boards words exact. 16 weeks plus a month puts the Tox study data right where Final results would be due. IMO, I think we will get Tox data after final results. Possibly at the end of Nov but before notifications of AGM. News of a deal could come any point after 18th Sept. I personally think we will get to know the next steps just before the AGM is announced.

Sorry final results in Oct will include a round up of progress so far. It will be interesting if they delay the interim results or push them out early.

Yes, interim results in Oct will include a round up of progress so far. It will be interesting if they delay the interim results or push them out early.

I think the publishing of P1 manuscript is a curious decision. There obviously is some value in doing so but who does it benefit? Is it to appease shareholders? I can't imagine it is being done to get the data out there. Surely, if anyone is interested, they'd setup a meeting and present the data? For shareholders, it's another positive RNS I suppose and there may be an SP spike with that but all eyes are surely on the Tox study? Maybe, once published, Sareum and others can tweet the link? I hope we get an RNS just not sure why they would do it before Tox data is in.

If my daughter wasn't just about to start her 3rd year at uni. I would add more. She's bleeding us dry at the moment. If anyone wanted a steady income after SAR come good. Be a landlord in York! They don't even bother to wear masks when they rob the students.

I've stopped buying so many times this year! Ha ha. I round up my shares to 350k but really, its 346902. Maybe just one last purchase of 3098 shares?

The clock is ticking on all warrants but for now there isn't any reason to excise warrants unless you want to sell. So I guess all will be sold. The only scenario I can think where you would need the warrants now is if a dividend was being paid. Think we a while from that. Although. If 737 was sold, they could potentially have a cash pile that is more than needed so any excess could be paid to shareholders as a special dividend! We can dream I suppose.

Ripley, it isn't really any your business what shares I own. However. In this case. I have traded AIM stocks for more than 15 years. Mostly, I have done ok. Up rather than down but over the last 5 years, I weaned my self off the AIM stock. I hold and add SAR and sometimes trade the like of pyc and kod. They, like SAR have a tendancy to spike on RNS. I always take profit on those. Never hold past the RNS. Fingers crossed, the luck will continue. My SIPP is mostly ETF's and SAR with some cash. Halifax pay 3.5% on cash so sometimes it is better being out of the market rather than in. So I guess, my answer is yes SAR is my only share, sort of.

Billy gave a figure of 156213164. This covers all warrants. If taken up. This is what I use for my calculations.

All but 50k (my pre RF purchases)of my shares have been purchased under 17p, with the majority purchased under 14p. I'm not selling any until we get near a pound. In fact, I will keep adding each month until then.

What are the risks?

I have reservations around 737. It has been passed around and overlooked too much for my liking but I feel it isn't fully priced in here anyway so we will see what Parker has in store for 737.

Whilst an extended tox study can't 'fail' we could fail to reach the required level of dosage needed to progress into Phase 2. at around 10 weeks in, I think we may have already passed the level needed and the board still seem pretty confident of a successful outcome.

Funding has been a massive weight around Sareum's neck. It has been a constant drag on the SP. If no deal comes before the end of the year. We will almost certainly see a fundraise, but between now and then. I don't see any major risks other than the day to day AIM fluctuations.

Its a Buy or at least hold for me.

so other than those two. I don't see any

Not really advice but when you roughly factor in the 1 to 50 consolidation and the subsequent share dilution, then the current SP of 26.7p equates to around 1p in old money (2020). As most here know, the SP went on a bit of a ride to 9p on little more than HNWI investment and covid rumours. Notwithstanding the RF financing that almost ended Sareum and decimated shareholder sentiment. We are much further on now with the potential for additional compounds in the pipeline. Other than the obvious, there is no reason why this can't 10 bag from here and even that would be below sector valuations for similar compounds. 26p is the equivalent of buying under a penny in 2020.

Ripley - I have 350k shares across my ISA and SIPP. I'm up around £40k just in the last week. I'm only up because I purchased low. If the SP gets to 50p and I believe it will before Dec, then 30p will seem like a bargain. If the SP reaches a pound, then 30p will be a multi-bagger. I'm not trying to sway anyone to buy or sell, but the LTH that made big profits in 2021 did so because they purchased at a super low price. With all things equal, we are back in the sweet spot where potential rewards are greater than the risk involved. No certainties, of course, but I believe you will get your pound and personally believe we could get a minimum of £3 if we can hold our nerve. Only invest that what you can afford to lose.

We know there is news due, publishing of phase 1 data for review and 737 for starters. It would be nice to get notifications of progress for both before the 1801 Tox study report. Could (and should) be 50p before the end of q4.

Hey basset. When I did my AI valuations. A preclinical 1802 with validation e.g. 1801 progression was 'valued' at £48 million. I would imagine a CNS compound would around the same for pre clinical. As SOG always points out. The extended toxicology study is of up most importance here. The results will make it break Sareum.

If as the company keeps stating. The strategy is to on licence the compounds. Then there will always be a drag on the share price. Each milestone reached (or failed) will see increased trade volumes. I have a mixture of shares. Some in my ISA and some in my sipp. For obvious reasons, I am more risk adverse with my SIPP shares all of which where purchased in the teens. It would be very hard to not sell those if the SP reaches £1, certainly if it got near £2. With my ISA shares, I more willing to risk holding those for phase 2. A buyout would be clean and would take away some of the stress of timing your exit.

I honestly believe that after the tox study and AI discovery that Sareums, 'pipeline in a compound" could be worth a minimum of £500 million. IMO, the only reason we aren't there is cash pile. If we had a cash runway of 2 to 3 years with funds to do our own phase 2, we could add a couple of hundred million to the market cap right now.

If as the company keeps stating. The strategy is to on licence the compounds. Then there will always be a drag on the share price. Each milestone reached (or failed) will see increased trade volumes. I have a mixture of shares. Some in my ISA and some in my sipp. For obvious reasons, I am more risk adverse with my SIPP shares all of which where purchased in the teens. It would be very hard to not sell those if the SP reaches £1, certainly if it got near £2. With my ISA shares, I more willing to risk holding those for phase 2. A buyout would be clean and would take away some of the stress of timing your exit.

I honestly believe that after the tox study and AI discovery that Sareums, 'pipeline in a compound" could be worth a minimum of £500 million. IMO, the only reason we aren't there is cash pile. If we had a cash runway of 2 to 3 years with funds to do our own phase 2, we could add a couple of hundred million to the market cap right now.

For the the record. I still believe 2 billion could be a fair valuation at the end of a successful phase 2 for 1801. More if the CNS indication is in play too. For me, any negotiation before that point should be starting at £500 million. Id take that for an early get out. Info think £800 million is a fair price though

I have also been thinking that 737 could sold separately. A cash windfall for compound development and maybe even a special dividend payment for shareholders. That would really put the cat amongst the pigeons!

At least a 100% dillution since then though. Not sure what the market cap was at the time of the HNWI investments. Market cap is a more accurate number when comparing all time highs and lows.